Doctors back Moderna, Merck cancer vaccine data
CNBC · RSS · · AI-summarised by FinFlash
Six melanoma specialists said the Moderna and Merck vaccine results represent a clinically meaningful outcome for melanoma patients who underwent surgery, even as Wall Street's reaction was muted. The physicians' endorsement contrasts with the market's cooler reception to the data. For investors, the specialist support suggests the clinical case may outlast the initial share price response.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.